Clinical Trial Update: Categorizing Patient Risk for Tricuspid Regurgitation (TR) Intervention With Admittance Pulmonary Artery Catheter System (APACS)

View source ↗

Summary

This clinical trial update notes that the study evaluating risk categorization for tricuspid regurgitation intervention using the Admittance Pulmonary Artery Ca…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tricuspid Regurgitation

Drugs mentioned

• Admittance Pulmonary Artery Catheter System (APACS)

Snippet

Sponsor: Feldman Cardiology, PLLC | Conditions: Tricuspid Regurgitation (TR) | Status: NOT_YET_RECRUITING